ERAP2 Inhibition Induces Cell-Surface Presentation by MOLT-4 Leukemia Cancer Cells of Many Novel and Potentially Antigenic Peptides

Recent studies have linked the activity of ER aminopeptidase 2 (ERAP2) to increased efficacy of immune-checkpoint inhibitor cancer immunotherapy, suggesting that pharmacological inhibition of ERAP2 could have important therapeutic implications. To explore the effects of ERAP2 inhibition on the immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Temponeras, Ioannis, Stamatakis, George, Samiotaki, Martina, Georgiadis, Dimitris, Pratsinis, Harris, Panayotou, George, Stratikos, Efstratios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836666/
https://www.ncbi.nlm.nih.gov/pubmed/35163832
http://dx.doi.org/10.3390/ijms23031913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836666/
https://www.ncbi.nlm.nih.gov/pubmed/35163832
http://dx.doi.org/10.3390/ijms23031913

Ejemplares similares